N4-Hydroxycytidine-13C,15N2
Stock Status: In Stock
Login to view price
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
N4-Hydroxycytidine-13C,15N2 Product Information
N4-Hydroxycytidine-13C,15N2 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Cytidine. The product is supplied by Clearsynth under CAT No. CS-O-40149.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
N4-Hydroxycytidine-13C,15N2
CAT No.
CS-O-40149
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C813CH13N15N2O6
Molecular Weight
262.20
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
N4-Hydroxycytidine-13C,15N2 is supplied with detailed characterization data compliant with regulatory guideline. N4-Hydroxycytidine-13C,15N2 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Cytidine.
Overview
EIDD 1931-13C,15N2 is a labelled EIDD 1931(E985800), which is an orally bioavailable broad-spectrum antiviral that inhibits SARS-CoV-2 and other multiple endemic, epidemic and bat coronavirus and has the potential for seasonal and pandemic influenza treatment. A broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses.
Synonyms
N4-Hydroxycytidine-13C,15N2
Application Notes
EIDD 1931-13C,15N2 is a labelled EIDD 1931(E985800), which is an orally bioavailable broad-spectrum antiviral that inhibits SARS-CoV-2 and other multiple endemic, epidemic and bat coronavirus and has the potential for seasonal and pandemic influenza treatment. A broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.